Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma

NCT06822855 is registered in ClinicalTrials.gov with Azienda USL Reggio Emilia - IRCCS as lead sponsor.

NCT NCT06822855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06822855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
Lead sponsor
Azienda USL Reggio Emilia - IRCCS
Phase
Observational
Overall status
Recruiting
Start date
June 23, 2022
Completion date
December 31, 2026
Enrollment
755 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

classical hodgkin lymphoma, classical hodgkin lymphoma recurrent, classical hodgkin lymphoma refractory